| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
68,309 |
59,030 |
$4.03M |
| 99199 |
Unlisted special service, procedure or report |
401,152 |
192,867 |
$1.99M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
14,121 |
12,352 |
$1.27M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
19,947 |
18,316 |
$914K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
4,619 |
3,832 |
$614K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,138 |
4,734 |
$451K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,949 |
3,665 |
$337K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,299 |
2,104 |
$203K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
6,340 |
5,473 |
$180K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,670 |
1,536 |
$160K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
10,440 |
9,688 |
$139K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
11,251 |
10,251 |
$109K |
| 99051 |
|
4,045 |
3,717 |
$100K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
6,053 |
2,913 |
$80K |
| 87070 |
|
7,942 |
7,349 |
$80K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
7,160 |
6,513 |
$65K |
| D0145 |
Oral evaluation for a patient under three years of age |
1,085 |
1,030 |
$36K |
| 99401 |
|
709 |
588 |
$24K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,128 |
1,052 |
$22K |
| D1206 |
Topical application of fluoride varnish |
1,083 |
1,028 |
$16K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
346 |
287 |
$13K |
| 96127 |
|
2,740 |
2,444 |
$13K |
| 92551 |
|
11,562 |
10,542 |
$9K |
| 90686 |
|
5,344 |
4,911 |
$8K |
| 96161 |
|
1,421 |
1,337 |
$5K |
| 90651 |
|
285 |
271 |
$3K |
| 0071A |
|
57 |
49 |
$3K |
| 90734 |
|
240 |
224 |
$3K |
| 0072A |
|
41 |
41 |
$3K |
| 99173 |
|
13,319 |
12,147 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
82 |
64 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
188 |
166 |
$2K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
24 |
24 |
$2K |
| 90474 |
|
76 |
76 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
38 |
38 |
$407.20 |
| 36415 |
Collection of venous blood by venipuncture |
130 |
113 |
$325.04 |
| 81002 |
|
105 |
93 |
$315.00 |
| 81000 |
|
97 |
88 |
$300.56 |
| 90461 |
|
25 |
25 |
$107.80 |
| 99177 |
|
49 |
42 |
$28.71 |
| 3008F |
|
12,023 |
10,755 |
$0.00 |
| 99000 |
|
6,419 |
5,437 |
$0.00 |
| 90647 |
|
1,286 |
1,177 |
$0.00 |
| 90723 |
|
1,303 |
1,204 |
$0.00 |
| 94760 |
|
195 |
187 |
$0.00 |
| 90677 |
|
341 |
340 |
$0.00 |
| 90716 |
|
192 |
164 |
$0.00 |
| 90656 |
|
400 |
387 |
$0.00 |
| 36416 |
|
28 |
27 |
$0.00 |
| 90620 |
|
30 |
25 |
$0.00 |
| 91307 |
|
114 |
102 |
$0.00 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
12 |
12 |
$0.00 |
| 90670 |
|
2,564 |
2,322 |
$0.00 |
| 90707 |
|
191 |
163 |
$0.00 |
| 90681 |
|
141 |
131 |
$0.00 |
| 90685 |
|
26 |
26 |
$0.00 |
| 91300 |
|
47 |
39 |
$0.00 |
| 90633 |
|
257 |
239 |
$0.00 |